2018
DOI: 10.1007/s10815-018-1190-9
|View full text |Cite
|
Sign up to set email alerts
|

Does the endometrial receptivity array really provide personalized embryo transfer?

Abstract: Performing the ERA test in a mock cycle prior to a FET does not seem to improve the ongoing pregnancy rate in good prognosis patients. Further large prospective studies are needed to elucidate the role of ERA testing in both good prognosis patients and in patients with recurrent implantation failure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
83
0
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 106 publications
(91 citation statements)
references
References 10 publications
5
83
0
3
Order By: Relevance
“…Considering how critical the molecular signature of the endometrium is for embryo implantation, a test which unequivocally assess if the embryo and the uterus are in synchrony may be of great value to avoid ineffective embryo transfers. However, the utility of ERA in the clinical practice is still debated [203]. More recently, a smaller set of genes has been proposed to assess the receptivity status of the endometrium in biopsies obtained in the secretory phase [204].…”
Section: Endometrial Receptivity Arraymentioning
confidence: 99%
“…Considering how critical the molecular signature of the endometrium is for embryo implantation, a test which unequivocally assess if the embryo and the uterus are in synchrony may be of great value to avoid ineffective embryo transfers. However, the utility of ERA in the clinical practice is still debated [203]. More recently, a smaller set of genes has been proposed to assess the receptivity status of the endometrium in biopsies obtained in the secretory phase [204].…”
Section: Endometrial Receptivity Arraymentioning
confidence: 99%
“…57,72 However, optimal timing may vary between individuals, with research continuing to identify histological or genomic tests to determine the personalised window of implantation. [73][74][75][76][77][78] There is reasonable evidence that estrogen can be continued for several weeks before the introduction of progesterone in medicated FER with no adverse effect on clinical pregnancy rate. 79 Consequently, medicated FER offers flexibility over timing of embryo transfer, which is convenient for women and when managing clinic workflow.…”
Section: Hormone Replacement (Medicated) Frozen-thawed Embryo Replacementioning
confidence: 99%
“…45 While this test is currently on offer commercially, there remains limited evidence of benefit for improving live birth both in good prognosis patients and in patients with RIF. [45][46][47] The older patient With the rapid decline in fecundity seen with advancing female age, coupled with the societal changes in preferred age for child-bearing, fertility is primarily becoming a disease of ageing. 48 Unlocking the means to improve the fertility potential of the ageing oocyte is the next frontier for 21st century ART and for developed societies.…”
Section: Advances In Endometrial Biologymentioning
confidence: 99%
“…An endometrial biopsy is collected in the mid‐luteal phase with results denoted as ‘pre‐receptive’, ‘receptive’ or ‘post‐receptive’, with as many as one in four patients having a non‐receptive endometrium, allowing adjustment of the timing of embryo transfer in a subsequent cycle . While this test is currently on offer commercially, there remains limited evidence of benefit for improving live birth both in good prognosis patients and in patients with RIF …”
Section: Introductionmentioning
confidence: 99%